Improve posture and trunk flexibility

Trial ID
NCT06536478
Official Title
The Effect of Exercise Intervention on Posture, Trunk Flexibility and Spine Function in Patients With Parkinson's Disease
Goal
Improve posture and trunk flexibility
Phase
NA
Status
RECRUITING
Sponsor
National Taiwan University Hospital
Study Type
INTERVENTIONAL
Enrollment
40 participants
Conditions
Parkinson Disease
Interventions
exercise, education

Summary For Families

It aims to reduce stooped posture and improve trunk flexibility and spine function in Parkinson's, which can ease back pain and help balance. The program uses supervised exercise plus education that focuses on strengthening back extensor and core muscles, stretching tight trunk muscles, posture training, and mobility drills to increase spinal range of motion and teach safer alignment during daily activities. Because it is a non-drug intervention, it does not change how levodopa works; instead it targets the muscle weakness and stiffness that medications usually do not fix. The trial is looking for people aged 30 to 85 with Parkinson's at Hoehn and Yahr stage 2 to 3 who are medically stable, able to follow instructions, and compliant with medications, excluding those with dementia, recent musculoskeletal injuries or surgery, cardiopulmonary limits, or acute neurological problems.

Locations

  • National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan

Frequently Asked Questions

What is this trial testing?
This trial is studying exercise. It aims to reduce stooped posture and improve trunk flexibility and spine function in Parkinson's, which can ease back pain and help balance. The program uses supervised exercise plus education that focuses on strengthening back extensor and core muscles, stretching tight trunk muscles, posture training, and mobility drills to increase spinal range of motion and teach safer alignment during daily activities. Because it is a non-drug intervention, it does not change how levodopa works; instead it targets the muscle weakness and stiffness that medications usually do not fix. The trial is looking for people aged 30 to 85 with Parkinson's at Hoehn and Yahr stage 2 to 3 who are medically stable, able to follow instructions, and compliant with medications, excluding those with dementia, recent musculoskeletal injuries or surgery, cardiopulmonary limits, or acute neurological problems.
Who can participate?
Participants must be between 30 Years and 85 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 2 years and 10 months.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov